Kenneth D. Doig

发表

Canary: an atomic pipeline for clinical amplicon assays

Andrew Fellowes, Jason Ellul, Piers Blombery, 2017, BMC Bioinformatics.

PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories

Jason Li, Jason Ellul, Anthony T. Papenfuss, 2017, Genome Medicine.

Complete Genome Sequence of the Frog Pathogen Mycobacterium ulcerans Ecovar Liflandii

Torsten Seemann, Marnix H. Medema, Kenneth D. Doig, 2012, Journal of bacteriology.

Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory

Kenneth D. Doig, K. Doig, A. Fellowes, 2017, Annals of Hematology.

“Cancer 2015”: A Prospective, Population-Based Cancer Cohort—Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic

David M. Thomas, John J. McNeil, Brett Doble, 2015, Journal of personalized medicine.

On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer

Kenneth D. Doig, K. Holt, F. Portaels, 2012, BMC Genomics.

Homologous Recombination Repair Deficiency: An Overview for Pathologists.

Kenneth D. Doig, K. Doig, A. Fellowes, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnostics

Piers Blombery, Kenneth D. Doig, Kenneth Douglas Doig, 2021, BMC Medical Genomics.

Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer.

Kenneth D. Doig, S. Fereday, D. Bowtell, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation.

Kenneth D. Doig, K. Friend, J. Pearson, 2022, American journal of human genetics.

Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic Melanoma.

Kenneth D. Doig, Gisela Mir Arnau, D. Bowtell, 2017, JCO precision oncology.

ASXL1 c.1934dup;p.Gly646Trpfs*12—a true somatic alteration requiring a new approach

Kenneth D. Doig, E. Thompson, G. Ryland, 2017, Blood Cancer Journal.

TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members

Dale W. Garsed, Kenneth D. Doig, L. Andrews, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Canary: an atomic pipeline for clinical amplicon assays

Kenneth D. Doig, A. Papenfuss, E. Thompson, 2017, BMC Bioinformatics.

Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia

Anthony T Papenfuss, Piers Blombery, Yih-Chih Chan, 2017, Nature Communications.

Decreased Vancomycin Susceptibility in Staphylococcus aureus Caused by IS256 Tempering of WalKR Expression

Kenneth D. Doig, T. Seemann, K. Doig, 2013, Antimicrobial Agents and Chemotherapy.

Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary

David M. Thomas, Kenneth D. Doig, R. Tothill, 2013, The Journal of pathology.

Tumour mutational burden: an overview for pathologists.

Kenneth D. Doig, K. Doig, A. Fellowes, 2022, Pathology.

Studying cancer genomics through next-generation DNA sequencing and bioinformatics.

Jason Li, Maria A Doyle, Kenneth D. Doig, 2014, Methods in molecular biology.

Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing

David M. Thomas, Kenneth D. Doig, S. Fox, 2014, BMC Medical Genomics.

Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes.

Kenneth D. Doig, S. Dawson, M. Dawson, 2017, Blood.

Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients

Kenneth D. Doig, S. Fox, A. Dobrovic, 2015, British Journal of Cancer.

Bioinformatics Pipelines for Targeted Resequencing and Whole-Exome Sequencing of Human and Mouse Genomes: A Virtual Appliance Approach for Instant Deployment

Kenneth D. Doig, I. Saeed, S. Halgamuge, 2014, PloS one.

PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories

Kenneth D. Doig, M. Doyle, A. Papenfuss, 2017, Genome Medicine.

Complete Genome Sequence of the Frog Pathogen Mycobacterium

Kenneth D. Doig, M. Medema, Honglei Chen, 2012 .

Exploring the feasibility and utility of exome‐scale tumour sequencing in a clinical setting

Dishan M. Herath, Kenneth D. Doig, S. Fox, 2018, Internal medicine journal.

Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary

David M. Thomas, Kenneth D. Doig, R. Tothill, 2013, The Journal of pathology.

Clinical cancer genomic analysis: data engineering required.

Kenneth D. Doig, S. Fox, A. Papenfuss, 2015, The Lancet. Oncology.

Decreased Vancomycin Susceptibility in Staphylococcus aureus Caused by IS256 Tempering of WalKR Expression

Brian T. Tsuji, Kenneth D. Doig, T. Seemann, 2013, Antimicrobial Agents and Chemotherapy.

Decreased Vancomycin Susceptibility in Staphylococcus aureus caused by IS 256 Tempering of 1 WalKR Expression 2 3

Brian T. Tsuji, Kenneth D. Doig, T. Seemann, 2013 .

Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes.

Kenneth D. Doig, S. Dawson, M. Dawson, 2017, Blood.